Coronavirus vaccine: Where are we and what's next?
Reactions Science Videos | April 1, 2020
You might have heard that COVID-19 vaccine trials are underway in Seattle. What exactly is being tested? How much longer will these tests take? And when can we expect a vaccine against the novel coronavirus? We chat with Benjamin Neuman, Ph.D., one of the world’s experts on coronavirus, and Daniel Wrapp, one of the scientists who mapped the structure of the protein that the coronavirus uses to infect your cells, to help us answer these questions
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
A Fusion Peptide in the Spike Protein of MERS Coronavirus
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
How SARS hijacks host cells
Mechanisms of viral assembly
Timely development of vaccines against SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
Scientists figure out how new coronavirus breaks into human cells
A Spotlight on Viruses—Application of Click Chemistry to Visualize Virus-Cell Interactions
How Viruses Invade Cells
The proximal origin of SARS-CoV-2
Thousands of scientists are racing to find a vaccine for coronavirus. 41 possibilities are in the works
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
New coronavirus stable for hours on surfaces
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
Vaccines and Antiviral Drugs in Pandemic Preparedness
On the binding affinity of macromolecular interactions: daring to ask why proteins interact
Coronavirus envelope protein: current knowledge
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Produced by the American Chemical Society.